Keith W. Schmidt

Keith W. Schmidt

74 year
Health Technology
Consumer Services

Profile

Keith W.
Schmidt
served as Vice President at Syntex Laboratories, Inc. and Hoffmann-La Roche, Inc. He was also the Vice President of Sales & Marketing at Chelsea Therapeutics International Ltd.
from 2006 to 2012 and later became the Chief Commercial Officer in 2014.
Schmidt was the President of Tellico Pharma LLC and Vice President at Thomson Healthcare Advanced Therapeutics Communications.
He also served as the Chief Commercial Officer at Ballantyne Therapeutics, Inc. Schmidt earned an undergraduate degree from South Dakota State University and an MBA from the University of San Francisco.

Former positions of Keith W. Schmidt

CompaniesPositionEnd
AVALO THERAPEUTICS, INC. Director/Board Member 17/06/2020
CHELSEA THERAPEUTICS INTERNATIONAL LTD. Corporate Officer/Principal 22/06/2014
CHELSEA THERAPEUTICS INTERNATIONAL LTD. Sales & Marketing 09/07/2012
Thomson Healthcare Advanced Therapeutics Communications Corporate Officer/Principal 30/04/2005
Corporate Officer/Principal -
See the detail of Keith W. Schmidt's experience

Training of Keith W. Schmidt

South Dakota State University Undergraduate Degree
University of San Francisco Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith W. Schmidt's experience

Connections

24

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
AVALO THERAPEUTICS, INC.

Health Technology

Private companies6

Health Technology

Tellico Pharma LLC

Thomson Healthcare Advanced Therapeutics Communications

Health Technology

Syntex Laboratories, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Keith W. Schmidt